Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.190
+0.150 (4.93%)
At close: Apr 28, 2026, 4:00 PM EDT
3.200
+0.010 (0.31%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $29.93 million as of April 28, 2026.
Market Cap
29.93M
Enterprise Value
-589.70K
1-Year Change
n/a
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $29.93M, a decrease of -82.47%. That is a compound annual growth rate of -81.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 28.52M | -29.30% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 31.34M |
| Daré Bioscience | 30.72M |
| Lisata Therapeutics | 28.90M |
| Kyntra Bio | 28.89M |
| Apollomics | 28.52M |
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |